5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Acutaas Chemicals Ltd.

•
acutaas.comBSE: 543349NSE: ACUTAAS
Market Cap₹ 26,194 Cr.
Current Price
High / Low₹ 3,740 / 1,302
Stock P/E65.9
Book Value₹ 213
Price to Book12.58
Dividend Yield0.08 %
ROCE32.9 %
ROE24.6 %
Face Value₹ 5

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 46.6% CAGR over last 5 years
  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 21.0%
  • Latest quarter profit grew 70.0% YoY, showing strong momentum
  • Company has delivered good sales growth of 31.2% CAGR over last 5 years
  • Operating margins have improved to 36.5% from 20.6%

CONS

  • Promoter holding has decreased over last 2 years: -3.3pp
  • Free cash flow has been persistently negative
  • Total debt has risen sharply - up 278.8% year on year
  • Stock is trading at 12.6x its book value
  • Equity base is being diluted - shares outstanding up 12.3%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1904.0037.77456833.380.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9245.0083.91245425.700.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4924.7085.89187319.760.77566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1135.0025.09113216.680.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1389.0033.29112211.540.94785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1872.1592.52101154.550.113620.702139.4220263.101191.0018.2031.50
7.LUPIN2135.0017.6697626.260.841416.9816.018276.8934.2828.8629.59
8.MANKIND2345.0047.4296859.070.04574.0929.124030.5912.8913.2426.30
9.DRREDDY1155.0029.9296405.530.69435.60-69.108099.80-5.2113.7510.63
10.AUROPHARMA1627.0025.2293613.980.251032.0325.229150.3517.4412.7620.54
11.GLENMARK2458.8038.6069393.400.10482.83927.884018.4831.3520.3520.03
12.ACUTAAS3199.4567.8226194.260.0874.9970.40329.6859.0832.4234.30
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
142164162220171244271304206305391422322
117145138180145195204220155209237241223
Operating Profit25192440264867845197154181100
OPM %17.82%11.39%14.55%18.26%15.37%19.76%24.60%27.64%24.76%31.65%39.45%42.96%30.87%
1-303929261696154
Interest1132401011111
Depreciation3344666778999
Profit before Tax23-162042185063835997151186104
Tax %25.17%-30.59%22.81%24.14%24.67%24.67%27.57%24.12%24.23%25.07%25.97%26.25%27.03%
Net Profit17-21163214384563457311213776
4.63-5.754.294.371.714.705.667.845.458.9013.6316.749.27

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1601882362403415206176889901,3241,440
137158193199260415494580765841909
Operating Profit2331434180105123108225483532
OPM %14.43%16.23%18.17%17.14%23.55%20.22%19.89%15.66%22.75%36.49%36.91%
0313134-18184634
Interest33566626634
Depreciation12344101215243335
Profit before Tax19283735729111269214493538
Tax %35.51%34.82%32.72%20.96%24.72%21.33%25.74%36.79%25.30%25.69%26.11%
Net Profit1218252754728344160366397
EPS80.33122.9323.468.7217.1421.0322.8711.8519.4944.73—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%15.19%13.12%25.33%7.70%5.59%—

COMPOUNDED SALES GROWTH

10 Years:
24%
5 Years:
31%
3 Years:
29%

COMPOUNDED PROFIT GROWTH

10 Years:
40%
5 Years:
47%
3 Years:
64%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
122%

RETURN ON EQUITY

10 Years:
26%
5 Years:
17%
3 Years:
16%
Last Year:
25%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2025

Sep 18

₹ 0.30

Rs.1.5000 per share(30%)Final Dividend

2024

Sep 13

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2023

Sep 18

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2022

Jul 29

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2026

Apr 30

₹ 0.50

Rs.2.5000 per share(50%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital221010323636374141
385671971324825506361,2711,624
23414854117131721132
Trade Payables3848695185118139133156151
891415441830936087
Total Liabilities1091552122284106557591,0711,5381,935
15155862161178222357499601
Capital Work in Progress11302120226125130228
152128283333336868118
2027395260112119151174227
0000000213289360
Cash & Bank31032995932241165
45618571154230301125137237
Total Assets1091552122284106557591,0711,5381,935

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
36183636411380101116305
Cash from Investing-19-27-25-24-101-122-20-337-234-334
Cash from Financing-7143072140-142352744
2-2-03-2821-1155-25

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
PER SHARE
EPS (₹)80.33122.9323.4626.1617.1419.7522.8711.8519.4944.73
Book Value (₹)262.32385.6977.25102.8452.05142.16161.04182.43160.19203.40
Dividend per Share (₹)0.000.000.000.000.003.003.003.001.502.50
Cash EPS (₹)2.133.234.324.923.0811.2613.137.9111.2148.76
PROFITABILITY
Operating Margin %14.57%17.76%18.66%18.30%23.94%20.75%20.59%15.66%22.75%36.49%
Net Margin %7.52%9.80%10.46%11.46%15.85%13.83%13.51%6.35%16.12%27.66%
ROE %36.07%37.94%35.45%29.06%39.72%21.10%15.09%6.94%16.08%24.60%
ROCE %35.80%37.76%35.02%26.68%33.05%23.88%20.67%10.22%19.99%32.94%
12.03%13.96%13.41%12.48%16.92%13.51%11.79%4.77%12.23%21.08%
EFFICIENCY
Debtor Days8384959592981161189390
Inventory Days45465169606168726055
Payable Days12813914217013813614212296100
-1-104-5142342685645
FINANCIAL HEALTH
Debt to Equity (x)0.67x0.75x0.66x0.55x0.83x0.00x0.01x0.30x0.00x0.01x
Interest Coverage (x)6.67x9.77x8.70x7.22x13.77x15.27x47.49x12.73x37.46x161.14x
1.21x1.33x1.14x1.23x1.28x3.30x2.79x1.75x3.89x3.62x
GROWTH
Revenue Growth %4.27%17.45%25.17%1.72%42.13%52.71%18.57%11.49%43.96%33.74%
Operating Profit Growth %10.89%43.16%31.54%-0.23%85.90%32.39%17.64%-4.36%100.47%117.22%
Net Profit Growth %-4.76%53.04%33.58%11.53%96.57%33.24%15.84%-47.58%265.22%129.51%
0.00%0.00%0.00%0.00%0.00%0.00%0.00%-48.21%64.53%129.50%
VALUATION
P/E (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x46.19x62.64x57.20x
P/B (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x6.00x15.24x12.58x
Dividend Yield %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.27%0.06%0.10%
0.00x0.00x0.00x0.00x0.00x0.00x0.00x34.64x81.13x39.34x

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
35.9835.9735.9635.9632.6632.6632.6632.6632.66
12.9313.8715.5216.4816.9416.8416.6719.4821.61
14.8119.9320.2318.3122.3822.5921.7019.6019.55
0.000.000.010.010.010.010.010.010.01
36.2930.2328.2729.2328.0127.8928.9628.2426.16

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04
General Updates

2026-09-04 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-08-31
Copy of Newspaper Publication

2026-08-31 - Acutaas Chemicals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-29
General Updates

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-08-29
Record Date

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange that Record date for the purpose of Dividend is 17-Sep-2026.

2026-08-29
Shareholders meeting

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-08-28
Press Release

2026-08-28 - Acutaas Chemicals Limited has informed the Exchange regarding a press release dated August 28, 2026, titled "Acutaas Chemicals step-down subsidiary Indichem inaugurates Semiconductor Materials Plant at Gongju, The Republic of Korea".

2026-08-24
Copy of Newspaper Publication

2026-08-24 - Acutaas Chemicals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-22
General Updates

2026-08-22 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-08-18
General Updates

2026-08-18 - Acutaas Chemicals Limited has informed the Exchange about General Updates

News

Recent coverage and analyst commentary for ACUTAAS

Loading news…

🤖

AI Stock Analyst

Acutaas Chemicals Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login